Thalidomide
Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
Product Specifications
CAS Number
50-35-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
258.23
Molecular Formula
C13H10N2O4
Notes
Research use only, not for human use.
Receptor
TNF-α
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
L3191-50-ML490 100 µL
LMTK2 (Lemur Tyrosine Kinase 2, LMR2, Apoptosis-associated Tyrosine Kinase 2, AATYK2, Brain-enriched Kinase, BREK, hBREK, CDK5/p35-regulated Kinase, CPRK, FLJ46659, KIAA1079, Kinase/phosphatase/inhibitor 2, KPI2, KPI-2, Serine/threonine-protein Kinase LMTK2, Serine/threonine-protein Kinase KPI-2) (MaxLight 490) discontinued
Ask
View Details 